A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
Yatsuda Y, Hirose S, Ito Y, Onoda T, Sugiyama Y, Nagafuchi M, Suzuki H, Niisato Y, Tange Y, Ikeda T, Yamada T, Yamamoto Y, Ohyama Osawa M, Sakamoto N, Moriwaki T, Mizokami Y.
Yatsuda Y, et al. Among authors: hirose s.
Intern Med. 2021 Apr 1;60(7):1011-1017. doi: 10.2169/internalmedicine.5893-20. Epub 2020 Nov 9.
Intern Med. 2021.
PMID: 33162479
Free PMC article.